Brief: Solara Active Pharma Sciences Says Closure Of US FDA Inspection Of Puducherry Facility
28/04/2026 14:16
April 28 (Reuters) - Solara Active Pharma Sciences Ltd SOLA.NS: SOLARA ACTIVE PHARMA SCIENCES - CLOSURE OF US FDA INSPECTION OF PUDUCHERRY FACILITY SOLARA ACTIVE PHARMA SCIENCES - FDA ISSUED EIR WITH CLASSIFICATION AS VOLUNTARY ACTION INDICATED Source text: [ID:] Further company coverage: SOLA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees